The glossy covers promised safer, natural alternatives to GLP1 (glucagon-like peptide-1) drugs such as Ozempic, touting ...

This occurred as the drug major Emcure Pharmaceuticals presented bioequivalence study report along with the Phase-III ...

Since its launch in June, Wegovy has recorded sales ₹10 crore until the end of July. Both Mounjaro (Tirzepatide) and Wegovy (Semaglutide) are GLP-1 (glucagon-like peptide-1) receptor agonists, which ...

Eli Lilly has launched Mounjaro in KwikPen, a prefilled pen for weekly administration, in India to treat type 2 diabetes and ...